Skip to main content

Advertisement

SpringerLink
Log in

The Management of Anxiety and Depressive Disorders: A Review

  • Published:
International Journal of Mental Health and Addiction Aims and scope Submit manuscript

Abstract

While anxiety and mild-moderate depression (the so-called neuroses) are the commonest mental disorders, they receive scant attention. They should be considered together, because they commonly occur together, are typically chronic, and respond to the same treatment. This review challenges traditional notions about the neuroses, by examining the reasons for their co-morbidity, the effectiveness of SSRIs in anxiety, and the biological basis of anxiety. From neuro-endocrine, psycho-immunology, genetic and clinical studies, anxiety and depression could denote manifestations of an underlying cause. Anxiety results from a dysregulation of homeostasis in the serotonin and noradrenergic systems, which SSRIs stabilize. Treatment guidelines recommend that SSRIs and SNRI should be first-line in the treatment of anxiety disorders, in combination with psychotherapy, with benzodiazepines used on short-term basis. Remission should be the goal of treatment. Outcome should include clinical, functional and disability assessments, graded in terms of response, remission and recovery. Perhaps the SSRIs and SNRI should be recognized as anti-neurotic. Mental disorders probably exist in a biological system with serotonin at the root of the neuroses, while dopamine sub-stands the psychoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., et al. (2004). Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica (Suppl.420), 21–27.

  • Allgulander, C., Bandelow, B., Hollander, E., Montgomery, S. A., Nutt, D. J., Okasha, A., et al. (2003). WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectrum, 8 (8 Suppl. 1), 53–61.

    Google Scholar 

  • Bakish, D. (1999). The patient with co-morbid depression and anxiety: the unmet need. Journal of Clinical Psychiatry, 60(Suppl. 6), 20–24.

    PubMed  Google Scholar 

  • Baldwin, D. S. (2000). Clinical experience with paroxetine in social anxiety disorder. International Clinical Psychopharmacology, 15(Suppl 1), S19–S24.

    PubMed  Google Scholar 

  • Coplan, J. D., & Lydiard, R. B. (1998). Brain circuits in panic disorder. Biological Psychiatry, 44, 1264–1276.

    Article  PubMed  CAS  Google Scholar 

  • Coplan, J. D., Papp, L. A., Martinez, J., Pine, D., Rosenblum, L. A., Cooper, T., et al. (1995). Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. American Journal of Psychiatry, 152, 619–622.

    PubMed  CAS  Google Scholar 

  • Coplan, J. D., Papp, L. A., Pine, D., Martinez, M. A., Cooper, T., Rosenblum, L. A., et al. (1997). Clinical improvement with fluoxetine therapy and nor-adrenergic function in patients with panic disorder. Archives of General Psychiatry, 54, 643–648.

    PubMed  CAS  Google Scholar 

  • Coplan, J. D., Tamir, H., Calaprice, D., De Jesus, M., dela Nuez, M., Pine, D., et al. (1999). Plasma anti-serotonin and serotonin anti-idiotypic antibodies are elevated in panic disorder. Neuropsychopharmacology, 20, 386–391.

    Article  PubMed  CAS  Google Scholar 

  • Coryell, W. (1988). Panic disorder and mortality. Psychiatric Clinics of North America, 11, 433–440.

    PubMed  CAS  Google Scholar 

  • Coryell, W., Endicott, J., & Winokur, G. (1992). Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. American Journal of Psychiatry, 149, 100–107.

    PubMed  CAS  Google Scholar 

  • Cox, B. J., Direnfeld, D. M., Swinson, R. P., & Norton, G. R. (1994). Suicidal Ideation and suicide attempts in panic disorder and social phobia. American Journal of Psychiatry, 151, 882–887.

    PubMed  CAS  Google Scholar 

  • Davidson, J. R., Bose, A., Korotzer, A., & Zheng, H. (2004). Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. Depression and Anxiety, 19, 234–240.

    Article  PubMed  CAS  Google Scholar 

  • De Graaf, R., Bijl, R. V., Smit, F., Vollenbergh, W. A., & Spijker, J. (2002). Risk factors for 12-month co-morbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. American Journal of Psychiatry, 159, 620–629.

    Article  PubMed  Google Scholar 

  • De Jonghe, F., Kool, S., van Aalst, G., Dekker, J., & Peen, J. (2001). Combining psychotherapy and antidepressants in the treatment of depression. Journal of Affective Disorders, 64, 217–229.

    Article  PubMed  Google Scholar 

  • Dupont, R. I., Rice, D. P., Shiraki, S., & Rowland, C. R. (1995). Economic costs of obsessive compulsive disorder. Medicine Interface, 8, 102–109.

    CAS  Google Scholar 

  • Duran, B., Sanders, M., Skipper, B., Waitzkin, H., Malcoe, L. H., Paine, S., & Yager, J. (2004). Prevalence and correlates of mental disorders among Native American women in primary care. American Journal of Public Health, 94, 71–77.

    Article  PubMed  Google Scholar 

  • Fava, M., Rankin, M. A., Wright, E. C., Alpert, J. E., Nierenberg, A. A., Pava, J., & Rosenbaum, J. F. (2000). Anxiety disorders in major depression. Comprehensive Psychiatry, 41, 97–102.

    Article  PubMed  CAS  Google Scholar 

  • Feighner, J. P. (1999). Overview of antidepressants currently used to treat anxiety disorders. Journal of Clinical Psychiatry, 60(Suppl. 22), 18–22.

    PubMed  CAS  Google Scholar 

  • Frances, A., Manning, D., Marin, D., Kocsis, J., McKinney, K., Hall, W., & Kline, M. (1992). Relationship of anxiety and depression. Psychopharmacology, 106 (Suppl.), 82–86.

    Article  Google Scholar 

  • Furukawa, T. A., McGuire, H., & Barbui, C. (2003). Low dosage tricyclic antidepressants for depression. Cochrane Database Systematic Review, (3), CD 003197.

  • Furukawa, T. A., Streiner, D. L., & Young, L. T. (2001). Is antidepressant–benzodiazepine combination therapy clinically more useful? A meta-analytical study. Journal of Affective Disorders, 65, 173–177.

    Article  PubMed  CAS  Google Scholar 

  • Goodwin, R. D., Fergusson, D. M., & Horwood, L. J. (2004). Panic attacks and psychoticism. American Journal of Psychiatry, 161, 88–92.

    Article  PubMed  Google Scholar 

  • Goodwin, R. D., & Gotlib, I. H. (2004). Panic attacks and psychopathology among youths. Acta Psychiatrica Scandinavica, 109, 216–221.

    Article  PubMed  CAS  Google Scholar 

  • Gorman, J. M., & Coplan, J. D. (1996). Comorbidity of depression and panic disorder. Journal of Clinical Psychiatry, 57(Suppl. 10), 34–41.

    PubMed  Google Scholar 

  • Harter, M. C., Conway, K. P., & Merikangas, K. R. (2003). Association between anxiety disorders and physical illness. European Archives of Psychiatry and Clinical Neurosciences, 253, 313–320.

    Article  Google Scholar 

  • Hirschfeld, R. M. (2001). The co-morbidity of major depression and anxiety disorders: recognition and management in primary care. Primary Care Companion of Journal of Clinical Psychiatry, 3, 244–254.

    Google Scholar 

  • Humphris, G. M., Rogers, S., McNally, D., Lee-Jones, C., Brown, J., & Vaughan, D. (2003). Fear of recurrence and possible cases of anxiety and depression in oro-facial cancer patients. International Journal of Oral Maxillofacial Surgery, 32, 486–491.

    Article  CAS  Google Scholar 

  • Johnson, J., Weissman, M. M., & Klerman, G. L. (1990). Panic disorder, co-morbidity and suicide attempts. Archives of General Psychiatry, 47, 805–808.

    PubMed  CAS  Google Scholar 

  • Jorm, A. F., Korten, A. E., Christensen, H., Jacomb, P. A, Rodgers, B., & Parslow, R. A. (2003). Association of obesity with anxiety, depression and emotional well-being: a community survey. Australia and New Zealand Journal of Public Health, 27, 434–440.

    Article  Google Scholar 

  • Kapczinnski, F., Lima, M. S., Souza, J. S., & Schimitt, R. (2003). Antidepressants for generalized anxiety disorder. Cochrane Database Systematic Review, (2), CD 003592.

  • Kara, S., Yazici, K. M., Gulec, C., & Unsal, I. (2000) Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biologic variables. Psychiatry Research, 94, 59–66.

    Article  PubMed  CAS  Google Scholar 

  • Karlidag, R., Unal, S., Evereklioglu, C., Sipahi, B., Er, H., & Yologlu, E. (2003). Stressful life events, anxiety, depression and coping mechanisms in patients with Behcet's disease. Journal of European Academy of Dermatology and Venerology, 17, 670–675.

    Article  CAS  Google Scholar 

  • Kawakami, N., Shimizu, H., Haratani, T., Iwata, N., & Kitamura, T. (2004). Lifetime and 6-month prevalence of DSM-111-R psychiatric disorders in an urban community in Japan. Psychiatry Research, 121, 293–301.

    Article  PubMed  Google Scholar 

  • Kendler, K. S. (2001). Twin studies of psychiatric illness: an update. Archives of General Psychiatry, 58, 1005–1014.

    Article  PubMed  CAS  Google Scholar 

  • Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C., & Eaves, L. J. (1992). Major depression and generalized anxiety disorder: same genes (partly) different environments? Archives of General Psychiatry, 49, 716–722.

    PubMed  CAS  Google Scholar 

  • Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biological Psychiatry, 44, 812–824.

    Article  PubMed  CAS  Google Scholar 

  • Kiloh, L. G., Andrews, G., Neilson, M., & Bianchi, G. N. (1972). The relationship of the syndromes called endogenous and neurotic depression. British Journal of Psychiatry, 121, 183–196.

    Article  PubMed  CAS  Google Scholar 

  • Kiloh, L. G., & Garside, R. F. (1963). The independence of neurotic depression and endogenous depression. British Journal of Psychiatry, 109, 451–463.

    Article  PubMed  CAS  Google Scholar 

  • Kjernisted, K. D., & Bleau, P. (2004). Long-term goals in the management of acute and chronic anxiety disorders. Canadian Journal of Psychiatry, 49(Suppl. 1), 51s–63s.

    Google Scholar 

  • Lalonde, P. (2003). Evaluating antipsychotic medications: predictors of clinical effectiveness. Canadian Journal of Psychiatry, 48(Suppl. 1), 3s–12s.

    Google Scholar 

  • Lam, R. W., & Kennedy, S. H. (2004). Evidence-based strategies for achieving and sustaining full remission in depression: focus on meta-analysis. Canadian Journal of Psychiatry, 49(Suppl. 1), 17s–26s.

    Google Scholar 

  • Lecrubier, Y., & Judge, R. (1997). Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative paroxetine panic study investigators. Acta Psychiatrica Scandinavica, 95, 153–160.

    Article  PubMed  CAS  Google Scholar 

  • Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992). Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Social Psychiatry and Psychiatric Epidemiology, 27, 78–82.

    Article  PubMed  CAS  Google Scholar 

  • Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R., & Pitts, C. D. (2002). A randomized, double-blind, fixed dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. Journal of Clinical Psychiatry, 63, 66–74.

    PubMed  CAS  Google Scholar 

  • Lochner, C., Mogotsi, M., du Toit, P. L., Kaminer, D., Niehaus, D. J., & Stein, D. J. (2003). Quality of life in anxiety disorders: a comparison of obsessive–compulsive disorder, social anxiety disorder and panic disorder. Psychopathology, 36, 255–262.

    Article  PubMed  Google Scholar 

  • Lydiard, R. B., & Bobes, J. (2000). Therapeutic advances: paroxetine for the treatment of social anxiety disorder. Depression and Anxiety, 11, 99–104.

    Article  PubMed  CAS  Google Scholar 

  • Malhi, G. S., Parker, G. B., Gladstone, G., Wilhelm, K., & Mitchell, P. B. (2002). Recognizing the anxious face of depression. Journal of Nervous and Mental Disorders, 190, 366–373.

    Article  Google Scholar 

  • Markowitz, J. S., Weissman, M. M., Oullette, R., Lish, J. D., & Klerman, G. L. (1989). Quality of life in panic disorder. Archives of General Psychiatry, 46, 984–992.

    PubMed  CAS  Google Scholar 

  • Masand, P. S., & Gupta, S. (2003). The safety of SSRIs in generalized anxiety disorder: any reason to be anxious? Expert Opinion in Drug Safety, 2, 485–493.

    Article  CAS  Google Scholar 

  • Massion, A. O., Warshaw, M. G., & Keller, M. B. (1993). Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. American Journal of Psychiatry, 150, 600–607.

    PubMed  CAS  Google Scholar 

  • McCurry, S. M., Gibbons, L. E., Logsdon, R. G., & Teri, L. (2004). Anxiety and nighttime behavioral disturbances: awakenings in patients with Alzheimer's disease. Journal of Gerontological Nursing, 30, 12–20.

    PubMed  Google Scholar 

  • McIntyre, R. S., & O'Donovan, C. (2004). The human cost of not achieving full remission in depression. Canadian Journal of Psychiatry, 49(Suppl. 1), 10s–16s.

    Google Scholar 

  • Melartin, T. K., Rytsala, H. J., Leskela, U. S., Lestela-Mielonen, P. S., Sokero, T. P., & Isometsa, E. T. (2002). Current co-morbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. Journal of Clinical Psychiatry, 63, 126–134.

    PubMed  Google Scholar 

  • Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004). Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD): a review. Nordic Journal of Psychiatry, 58, 65–70.

    Article  PubMed  Google Scholar 

  • Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Michsler, W., Beier, M., et al. (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosomatic Medicine, 66, 79–84.

    Article  PubMed  Google Scholar 

  • Noorbala, A. A., Bagheri, Yadzi, S. A., Yasamy, M. T., & Mohammad, K. (2004). Mental health survey of the adult population in Iran. British Journal of Psychiatry, 184, 70–73.

    Article  PubMed  CAS  Google Scholar 

  • O'Donovan, C. (2004). Achieving and sustaining remission in depression and anxiety disorders: introduction. Canadian Journal of Psychiatry, 49(Suppl.1), 5s–9s.

    Google Scholar 

  • Ohaeri, J. U. (1992) Experiences of isolated sleep paralysis in clinical practice in Nigeria. Journal of National Medical Association, 84, 521–523.

    CAS  Google Scholar 

  • Ohaeri, J. U. (1993) Interpreting the dreams of Nigerian psychiatric patients. Nigerian Medical Journal, 24, 65–68.

    Google Scholar 

  • Ohaeri, J. U. (1997) Experience of cognitive behaviour therapy in psychiatric practice in Nigeria. II. Illustrative case histories. African Journal of Medicine and Medical Sciences, 26, 197–201.

    PubMed  CAS  Google Scholar 

  • Ohaeri, J. U. (1998–1999) Experience of dreams with manifest content of food (Food dreams) among 431 Nigerians. Psychopathologie Africaine, 29(1):23–39.

    Article  Google Scholar 

  • Ohaeri, J. U., & Sunmola, A. M. (1994) The pattern of dreams of a sample of Nigerians. Journal of Analytical Psychology, 39, 361–372.

    Article  PubMed  CAS  Google Scholar 

  • Olusina, A. K., & Ohaeri, J. U. (2003). Subjective quality of life of recently discharged Nigerian psychiatric patients. Social Psychiatry and Psychiatric Epidemiology, 38, 707–714.

    Article  PubMed  Google Scholar 

  • Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004). Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of General Psychiatry, 61, 714–719.

    Article  PubMed  Google Scholar 

  • Parker, G., Hadzi-Pavlovic, D., Roussos, J., Wilhelm K., Mitchell P., Austin M. P., et al. (1998). Non-melancholic depression: the contribution of personality, anxiety and life events to sub-classification. Psychological Medicine, 28, 1209–1219.

    Article  PubMed  CAS  Google Scholar 

  • Pollack, M. H., & Marzol, P. C. (2000). Panic: course, complications and treatment of panic disorder. Journal of Psychopharmacology, 14(2 Suppl 1), S25–S30.

    PubMed  CAS  Google Scholar 

  • Rickels, K., & Rynn, M. (2002). Pharmacotherapy of generalized anxiety disorder. Journal of Clinical Psychiatry, 63(Suppl. 14), 9–16.

    PubMed  CAS  Google Scholar 

  • Ritchie, K., Artero, S., Beluche, I., Ancelin, M. L., Mann, A., Dupuy, A. M., et al. (2004). Prevalence of DSM-IV psychiatric disorders in the French elderly population. British Journal of Psychiatry, 184, 147–152.

    Article  PubMed  CAS  Google Scholar 

  • Royal Australia and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia. (2003). Australia and New Zealand clinical practice guidelines for treatment of panic disorder and agoraphobia. Australia and New Zealand Journal of Psychiatry, 37, 641–656.

    Article  Google Scholar 

  • Royal Australia and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. (2004). Australia and New Zealand clinical practice guidelines for treatment of depression. Australia and New Zealand Journal of Psychiatry, 38, 389–407.

    Article  Google Scholar 

  • Segal, Z. W., Whitney, D. K., Lam, R. W., & CANMAT Depression Work Group. (2001). Clinical guidelines for the treatment of depressive disorders. III. Psychotherapy. Canadian Journal of Psychiatry, 46(Suppl. 1), 29s–37s.

    Google Scholar 

  • Snyderman, S. H., Rynn, M. A., Bellew, K., & Rickels, K. (2004). Paroxetine in the treatment of generalized anxiety disorder. Expert Opinion in Pharmacotherapy, 5, 1799–1806.

    Article  CAS  Google Scholar 

  • Stein, D. J. (2004). Algorithms for primary care: an evidence based approach to the pharmacotherapy of depression and anxiety disorders. Primary Psychiatry, 11, 55–78.

    Google Scholar 

  • Stein, D. J., Berk, M., Els, C., Emsley, R. A., Gittelson, L., Wilson, D., et al. (1999). A double-blind placebo-controlled trial of paroxetine in the management of social phobia in South Africa. South Africa Medical Journal, 89, 402–406.

    CAS  Google Scholar 

  • Stein, D. J., Stein, M. B., Pitts, C. D., Kumar, R., & Hunter, B. (2002a). Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials. Journal of Clinical Psychiatry, 63, 152–155.

    PubMed  CAS  Google Scholar 

  • Stein, D. J., Versiani, M., Hair, T., & Kumar, R. (2002b). Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Archives of General Psychiatry, 59, 1111–1118.

    Article  PubMed  CAS  Google Scholar 

  • Tausig, M., Subedi, S., Broughton, C. L., Subedi, J., & Williams-Blangero, S. (2003). Measuring community mental health in developing societies: evaluation of a checklist format in Nepal. International Journal of Social Psychiatry, 49, 269–286.

    Article  PubMed  Google Scholar 

  • Tsao, J. C., Dobalian, A., Moreau, C., & Dobalian, K. (2004). Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. Journal of Nervous and Mental Disorders, 192, 111–118.

    Article  Google Scholar 

  • Tyrer, P. (2001). The case for cothymia: mixed anxiety and depression as a single diagnosis. British Journal of Psychiatry, 179, 191–193.

    Article  PubMed  CAS  Google Scholar 

  • Tyrer, P., Seivewright, H., Simmonds, S., & Johnson, T. (2001). Prospective studies of cothymia (mixed anxiety depression): how do they inform clinical practice? European Archives of Psychiatry and Neuroscience, 251(Suppl 2), II53–II56.

    Google Scholar 

  • Udofia, O. (2005). SSRI/TCA sequential therapy: a cost effective drug regime for the long term management of depression. Nigerian Journal of Medicine, 3(2), 33–37.

    Google Scholar 

  • van Ameringen, M., Allgulander, C., Bandelow, B., Griest, J. H., Hollander, E., Montgomery, S. A., et al. (2003). WCA recommendations for the long-term treatment of social phobia. CNS Spectrum, 8(8 Suppl. 1), 40–52.

    Google Scholar 

  • van den Heuvel, O. A., van de Wetering, B. J., Veltman, D. J., & Pauls, D. L. (2000). Genetic studies of panic disorder: a review. Journal of Clinical Psychiatry, 61, 756–766.

    PubMed  Google Scholar 

  • Wagstaff, A. J., Cheer, S. M., Matheson, A. J., Ormrod, D., & Goa, K. L. (2002). Spotlight on paroxetine in psychiatric disorders in adults. CNS Drugs, 16, 425–434.

    Article  PubMed  Google Scholar 

  • Young, E. A., Abelson, J. l. L., & Cameron, O. G. (2004). Effect of co-morbid anxiety disorders on the hypothalamic pituitary axis response to a social stressor in major depression. Biological Psychiatry, 56, 113–120.

    Article  PubMed  CAS  Google Scholar 

  • Zimmerman, M., Chelminski, I., & McDermut, W. (2002). Major depressive disorder and axis 1 diagnostic co-morbidity. Journal of Clinical Psychiatry, 63, 187–193.

    PubMed  Google Scholar 

  • Zohar, J., & Westenberg, H. G. (2001). Anxiety disorders: a review of tricyclic antidepressants and selective serotonin re-uptake inhibitors. Acta Psychiatrica Scandinavica, 403(Suppl), 39–49.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Psychological Medicine Hospital, Gamal Abdul Naser Road, P.O. Box 4081, Safat, Kuwait

    Jude U. Ohaeri

Authors
  1. Jude U. Ohaeri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jude U. Ohaeri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohaeri, J.U. The Management of Anxiety and Depressive Disorders: A Review. Int J Ment Health Addiction 4, 103–118 (2006). https://doi.org/10.1007/s11469-006-9016-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11469-006-9016-x

Keywords

Search

Navigation